Gene · 79679
NIH grants878
NIH grants whose papers are about the gene, through NIH's grant-paper links.
481 to 500 of 878
Download this page as JSON| Grant | Title | VTCN1 papers | Newest fiscal year |
|---|---|---|---|
| R01CA163722 | Defining mechanisms of extracellular communication for cancer therapy | 1 | 2017 |
| R01CA168628 | Restoring anti-tumor immunity in the microenvironment of head and neck cancer | 1 | 2017 |
| R01CA176846 | Oncogenic MLK3-Pak1 Signaling in ER Negative Breast Cancer | 1 | 2017 |
| R01CA178748 | Nanoparticle formulations of DNA repair inhibitors to improve chemoradiotherapy | 1 | 2017 |
| R01CA183560 | Reconstitution of Regulatory T Cells After Stem Cell Transplantation | 1 | 2017 |
| R01CA183605 | Effects of PGE2 on reconstitution of hematopoiesis and immunity after UCBT | 1 | 2017 |
| R01CA190122 | (PQB-4) Single cell analysis strategy for monitoring drug responses of tumors | 1 | 2017 |
| R01DE023935 | Human cytomegalovirus chromatin modifications in oral infection | 1 | 2017 |
| R01DE025340 | Immune Checkpoints and HPV-associated Head and Neck Cancers | 1 | 2017 |
| R01DK100664 | Hepatic Non-viral Gene Therapy | 1 | 2017 |
| R01GM103833 | Quantitative Analysis and Modeling of Microtubule Structure and Regulation | 1 | 2017 |
| R01HL087115 | Clinical Risk Factors for Primary Graft Dysfunction | 1 | 2017 |
| R01HL117654 | Hyperhomocysteinemia and HDL Metabolism | 1 | 2017 |
| R01MH101454 | Contrasting causal microRNAs in forebrain and midbrain COS hiPSC neural cells | 1 | 2017 |
| R01NS084912 | Modulating Autophagy to Eradicate HIV-1 from CNS Reservoirs | 1 | 2017 |
| R21AI127132 | Role of Myeloid Derived Suppressor Cells in Mycobacterium tuberculosis(Mtb)Reactivation in HIV-Mtb co-infected Individuals | 1 | 2017 |
| R21CA193038 | An integrated imaging tool for probing EGFR subcellular trafficking in real time | 1 | 2017 |
| R21CA205644 | (PQ11) Reversing exosome-mediated immune suppression - a novel strategy for cancer therapy | 1 | 2017 |
| R21NS096413 | Novel gene editing strategy for eliminating human neurotropic JCV in glial cells | 1 | 2017 |
| R33CA225291 | Area C: Genome-wide identification and targeting of resistance to cancer therapy | 1 | 2017 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/79679/grants?page=25